Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
IRADIMED CORP
Report date January 06, 2020 · Filed January 08, 2020
Section 16 reporting ended · disclosed 2020-01-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 43,315 |
Ending reported balance
After 2020-01-06 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2020-01-06 · Exercise / conversion · Acquired 15,625 · Balance 46,012 F1: On April 27, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on April 27, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Vesting and settlement of the restricted stock units were accelerated to January 6, 2020. F2: Restricted stock units convert into common stock on a one-for-one basis. Row 2 · 2020-01-06 · Tax withholding · Disposed 4,074 · Balance 41,938 F3: Forfeiture of shares to satisfy tax obligations related to stock units for which vesting and settlement were accelerated to January 6, 2020. No shares were sold in connection with this transaction. Row 3 · 2020-01-06 · Exercise / conversion · Acquired 738 · Balance 42,676 F4: Vesting of restricted stock units granted to the reporting person on December 4, 2017 for which vesting and settlement were accelerated to January 6, 2020. F2: Restricted stock units convert into common stock on a one-for-one basis. Row 4 · 2020-01-06 · Tax withholding · Disposed 180 · Balance 42,496 F3: Forfeiture of shares to satisfy tax obligations related to stock units for which vesting and settlement were accelerated to January 6, 2020. No shares were sold in connection with this transaction. Row 5 · 2020-01-06 · Exercise / conversion · Acquired 1,083 · Balance 43,579 F5: Vesting of restricted stock units granted to the reporting person on December 7, 2018 for which vesting and settlement were accelerated to January 6, 2020. F2: Restricted stock units convert into common stock on a one-for-one basis. Row 6 · 2020-01-06 · Tax withholding · Disposed 264 · Balance 43,315 F3: Forfeiture of shares to satisfy tax obligations related to stock units for which vesting and settlement were accelerated to January 6, 2020. No shares were sold in connection with this transaction. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 15,625 |
Reported balance
After 2020-01-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2020-01-06 · Exercise / conversion · Disposed 15,625 · Balance 15,625 F2: Restricted stock units convert into common stock on a one-for-one basis. F6: Vesting and settlement of the restricted stock units were accelerated to January 6, 2020. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 738 |
Reported balance
After 2020-01-06 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2020-01-06 · Exercise / conversion · Disposed 738 · Balance 738 F2: Restricted stock units convert into common stock on a one-for-one basis. F6: Vesting and settlement of the restricted stock units were accelerated to January 6, 2020. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,083 |
Reported balance
After 2020-01-06 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2020-01-06 · Exercise / conversion · Disposed 1,083 · Balance 1,083 F2: Restricted stock units convert into common stock on a one-for-one basis. F6: Vesting and settlement of the restricted stock units were accelerated to January 6, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: On April 27, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on April 27, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Vesting and settlement of the restricted stock units were accelerated to January 6, 2020.
F2: Restricted stock units convert into common stock on a one-for-one basis.
F3: Forfeiture of shares to satisfy tax obligations related to stock units for which vesting and settlement were accelerated to January 6, 2020. No shares were sold in connection with this transaction.
F4: Vesting of restricted stock units granted to the reporting person on December 4, 2017 for which vesting and settlement were accelerated to January 6, 2020.
F5: Vesting of restricted stock units granted to the reporting person on December 7, 2018 for which vesting and settlement were accelerated to January 6, 2020.
F6: Vesting and settlement of the restricted stock units were accelerated to January 6, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 06, 2020 Filed Jan 8, 2020 21:58 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 1,083 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-20-000024 · form4.xml · derivative · entry 9 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,083 Underlying: Common Stock · 1,083 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F6 · derivative.exercise_date: Vesting and settlement of the restricted stock units were accelerated to January 6, 2020. F6 · derivative.expiration_date: Vesting and settlement of the restricted stock units were accelerated to January 6, 2020. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:58 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 738 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-20-000024 · form4.xml · derivative · entry 8 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 738 Underlying: Common Stock · 738 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F6 · derivative.exercise_date: Vesting and settlement of the restricted stock units were accelerated to January 6, 2020. F6 · derivative.expiration_date: Vesting and settlement of the restricted stock units were accelerated to January 6, 2020. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:58 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-20-000024 · form4.xml · derivative · entry 7 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,625 Underlying: Common Stock · 15,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F6 · derivative.exercise_date: Vesting and settlement of the restricted stock units were accelerated to January 6, 2020. F6 · derivative.expiration_date: Vesting and settlement of the restricted stock units were accelerated to January 6, 2020. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:58 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 264 | $25.06 | $6,615.84 |
DisclosureSEC source: 0000898432-20-000024 · form4.xml · nonDerivative · entry 6 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,315 F3 · kind: Forfeiture of shares to satisfy tax obligations related to stock units for which vesting and settlement were accelerated to January 6, 2020. No shares were sold in connection with this transaction. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:58 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 1,083 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-20-000024 · form4.xml · nonDerivative · entry 5 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Vesting of restricted stock units granted to the reporting person on December 7, 2018 for which vesting and settlement were accelerated to January 6, 2020. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:58 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 180 | $25.06 | $4,510.80 |
DisclosureSEC source: 0000898432-20-000024 · form4.xml · nonDerivative · entry 4 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,496 F3 · kind: Forfeiture of shares to satisfy tax obligations related to stock units for which vesting and settlement were accelerated to January 6, 2020. No shares were sold in connection with this transaction. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:58 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-20-000024 · form4.xml · nonDerivative · entry 3 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: Vesting of restricted stock units granted to the reporting person on December 4, 2017 for which vesting and settlement were accelerated to January 6, 2020. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:58 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 4,074 | $25.06 | $102,094.44 |
DisclosureSEC source: 0000898432-20-000024 · form4.xml · nonDerivative · entry 2 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,938 F3 · kind: Forfeiture of shares to satisfy tax obligations related to stock units for which vesting and settlement were accelerated to January 6, 2020. No shares were sold in connection with this transaction. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:58 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 15,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-20-000024 · form4.xml · nonDerivative · entry 1 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On April 27, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on April 27, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Vesting and settlement of the restricted stock units were accelerated to January 6, 2020. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:16 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 1,082 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001420 · form4.xml · derivative · entry 3 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,248 Underlying: Common Stock · 1,082 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:16 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 264 | $22.88 | $6,040.32 |
DisclosureSEC source: 0000898432-19-001420 · form4.xml · nonDerivative · entry 2 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,387 Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:16 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 1,082 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001420 · form4.xml · nonDerivative · entry 1 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 20:24 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 738 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001351 · form4.xml · derivative · entry 3 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,476 Underlying: Common Stock · 738 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 20:24 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 180 | $22.28 | $4,010.40 |
DisclosureSEC source: 0000898432-19-001351 · form4.xml · nonDerivative · entry 2 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,569 Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 20:24 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001351 · form4.xml · nonDerivative · entry 1 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 27, 2019 Filed Apr 30, 2019 18:36 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-000796 · form4.xml · derivative · entry 3 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Stock · 15,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On April 27, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan and pursuant to the reporting person's employment agreement with Iradimed Corporation. The restricted stock units vest in four equal annual installments beginning on April 27, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On April 27, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan and pursuant to the reporting person's employment agreement with Iradimed Corporation. The restricted stock units vest in four equal annual installments beginning on April 27, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| April 27, 2019 Filed Apr 30, 2019 18:36 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 3,797 | $29.31 | $111,290.07 |
DisclosureSEC source: 0000898432-19-000796 · form4.xml · nonDerivative · entry 2 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,011 Read SEC document |
| April 27, 2019 Filed Apr 30, 2019 18:36 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 15,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-000796 · form4.xml · nonDerivative · entry 1 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:35 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 4,330 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001458 · form4.xml · derivative · entry 1 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,330 Underlying: Common Stock · 4,330 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 18:04 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 738 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001415 · form4.xml · derivative · entry 3 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,214 Underlying: Common Stock · 738 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 18:04 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 180 | $26.78 | $4,820.40 |
DisclosureSEC source: 0000898432-18-001415 · form4.xml · nonDerivative · entry 2 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,183 Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 18:04 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001415 · form4.xml · nonDerivative · entry 1 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 16:33 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 3,861 | $27.10 | $104,633.10 |
DisclosureSEC source: 0000898432-18-000904 · form4.xml · nonDerivative · entry 2 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,625 Read SEC document |
| August 08, 2018 Filed Aug 10, 2018 16:33 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 3,139 | $27.55 | $86,479.45 |
DisclosureSEC source: 0000898432-18-000904 · form4.xml · nonDerivative · entry 1 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,486 Read SEC document |
| April 27, 2018 Filed May 1, 2018 21:15 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-000558 · form4.xml · derivative · entry 2 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,875 Underlying: Common Stock · 62,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On April 27, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan and pursuant to the reporting person's employment agreement with Iradimed Corporation. The restricted stock units vest in four equal annual installments beginning on April 27, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On April 27, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan and pursuant to the reporting person's employment agreement with Iradimed Corporation. The restricted stock units vest in four equal annual installments beginning on April 27, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| April 27, 2018 Filed May 1, 2018 21:15 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 15,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-000558 · form4.xml · nonDerivative · entry 1 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 04, 2017 Filed Dec 6, 2017 19:47 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 2,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-045233 · doc1.xml · derivative · entry 1 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,952 Underlying: Common Stock · 2,952 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| April 27, 2017 Filed May 1, 2017 17:34 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-017664 · doc1.xml · derivative · entry 1 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires not disclosed F1 · security: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan and pursuant to the reporting person's employment agreement with Iradimed Corporation. The restricted stock units vest in four equal annual installments beginning on April 27, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan and pursuant to the reporting person's employment agreement with Iradimed Corporation. The restricted stock units vest in four equal annual installments beginning on April 27, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.